The authors detail the development of a set of decision support rules for application within a major academic medical center and across its affiliated community satellite sites.
Development and Implementation of De Novo Clinical Decision Support Rules at a Tertiary Cancer Center
Health Care Use and Costs Among Medicare Patients With Chronic Obstructive Pulmonary Disease Treated With Short-Acting Beta Agonists or Long-Acting Beta Agonists
Researchers report the benefits of COPD treatment with long-acting beta agonists.
Authors examine different cost control levers the government could use to affect drug pricing and have an impact on treatments selected within clinical pathways.
Effect of Route of Bortezomib Administration on Treatment Outcomes in Previously Untreated Patients with Multiple Myeloma: A Retrospective Analysis from US Community Oncology Practices
Researchers tested Bortezomib Administration on Treatment Outcomes in patients with myeloma.
ASCO Policy Statement on Clinical Pathways in Oncology Represents Great Progress for Clinical Pathways
Winston Wong, PharmD, explains how the recent policy statement released by the American Society of Clinical Oncology represents a significant step forward for clinical pathways as a whole.
Edward J Stepanski discusses the underlying tension between payers and providers with respect to the aims of clinical pathways and the recent policy statement released by the American Society of Clinical Oncology.
The essential role of patient navigation and care coordination services in helping patients to adhere to their treatment plans.
The authors discuss tactics for ensuring appropriate compliance with clinical pathways among health care providers in large-scale health networks.
This article provides a comprehensive review of psoriasis and of the practical obstacles encountered in optimizing care of patients with moderate-to-severe disease.
A Clinical Pathway to Reduce Time to Antibiotic Administration in Pediatric Cancer Patients With Fever and Potential Neutropenia
The authors present a novel clinical pathway for treating febrile pediatric patients on chemotherapy or recently post–stem cell transplant.